These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


101 related items for PubMed ID: 595005

  • 1. Mammalian erythrocyte metabolism and oxidant drugs.
    Harvey JW, Kaneko JJ.
    Toxicol Appl Pharmacol; 1977 Nov; 42(2):253-61. PubMed ID: 595005
    [No Abstract] [Full Text] [Related]

  • 2. Oxidation of glutathione by methylene blue is equivalent in G-6-PD deficient and normal erythrocytes.
    Kelner MJ, Alexander NM.
    Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):265-8. PubMed ID: 3715203
    [No Abstract] [Full Text] [Related]

  • 3. Theoretical considerations and models of red and white cell pentose cycles.
    Hodges JM, Grümer HD.
    Clin Chem; 1973 Mar; 19(3):330-7. PubMed ID: 4689104
    [No Abstract] [Full Text] [Related]

  • 4. [Resistance of erythrocytes of different ages to oxidants in persons with hereditary glucosephosphate dehydrogenase deficiency].
    Ermakova TA, Tokarev IuN, Kolodeĭ SV, Kulagin MN.
    Gematol Transfuziol; 1989 Mar; 34(3):45-8. PubMed ID: 2721908
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Factors influencing response of mammalian species to the methaemoglobin reduction test.
    Robin H, Harley JD.
    Aust J Exp Biol Med Sci; 1966 Oct; 44(5):519-26. PubMed ID: 5969921
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of oxidant agents on normal and G6PD-deficient erythrocytes.
    Bashan N, Makover O, Livne A, Moses S.
    Isr J Med Sci; 1980 May; 16(5):351-6. PubMed ID: 7399864
    [Abstract] [Full Text] [Related]

  • 12. Radiometric micromethod for quantitation of glucose utilization by the erythrocyte.
    Hutton JJ.
    Anal Biochem; 1972 Feb; 45(2):577-84. PubMed ID: 5060607
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Determination of superoxide dismutase (sod) in erythrocytes in glucose-6-phosphate dehydrogenase deficiency (G6PD-deficiency)].
    Grieger M, Schulz S.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983 Feb; 110(3):427-36. PubMed ID: 6194077
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Ferricyanide reduction by human erythrocytes in the presence of carriers of redox equivalents across the membrane].
    Tsybyshev VP, Kuznetsov AN.
    Izv Akad Nauk SSSR Biol; 1988 Feb; (1):64-74. PubMed ID: 3351101
    [No Abstract] [Full Text] [Related]

  • 19. Effect of ascorbic acid on copper-induced oxidative changes in erythrocytes of individuals with a glucose-6-phosphate dehydrogenase deficiency.
    Calabrese EJ, Moore GS, McCarthy MS.
    Bull Environ Contam Toxicol; 1983 Mar; 30(3):323-30. PubMed ID: 6850118
    [No Abstract] [Full Text] [Related]

  • 20. [Pathophysiology of erythrocyte metabolism].
    Staal GE.
    Ned Tijdschr Geneeskd; 1974 Sep 21; 118(38):1439-41. PubMed ID: 4410347
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.